Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Fort Lauderdale DUI Attorney Contends that Proposed Changes to DUI Legislation Could Place Users of Medical Marijuana at Greater Risk for DUI Prosecution
  • USA - English


News provided by

The Law Offices of Michael A. Dye, PA

Mar 19, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Fort Lauderdale DUI Attorney The Law Offices of Michael A. Dye, PA On Call 24 Hours a Day (954)990-0525
Fort Lauderdale DUI Attorney The Law Offices of Michael A. Dye, PA On Call 24 Hours a Day (954)990-0525

Fort Lauderdale, Florida (PRWEB) March 19, 2014 -- On January 27, 2014, the Supreme Court of Florida gave the green light for a referendum to amend the State Constitution with regard to the legalization of medical marijuana. Less than one month later, on February 19, 2014, Florida Senator Audry Gibson of Duval County filed Florida Senate Bill 1118 which proposes substantial changes to Florida’s DUI laws. Fort Lauderdale DUI attorney, Michael Dye, believes that the proposed changes to Florida Statute 316.193 would place users of medical marijuana at greater risk of being prosecuted for DUI.

If this bill is passed, a chemotherapy patient who ingested marijuana two days before getting pulled over would be guilty of DUI even though there is no active THC in his or her system and there would be no impact on his or her driving.

Post this

The proposed changes contained in Florida Senate Bill 1118 would only modify DUID cases. DUID cases are DUI cases that are proceeding on a drug impairment theory. Current Florida law requires the prosecution to prove actual impairment by a controlled substance, listed in Chapter 893 Florida Statutes, in order to obtain a conviction. With the seemingly inevitable legalization of medical marijuana on the horizon, Florida Senate Bill 1118, if passed, would drastically alter Florida’s DUI statute and provide no protection for users of medical marijuana. First, the bill adds all federally controlled substances to the DUI statue. Accordingly, in the event that marijuana is ever removed from Florida’s list of Schedule I controlled substances, it will remain a Schedule I controlled substance for purposes of DUI cases due to its federal classification. Second, Senate Bill 1118 would create a “metabolite DUI” provision. The metabolite DUI provision, as written, would eliminate the requirement that the prosecution prove that a driver is impaired by a controlled substance while in actual physical control of a motor vehicle.    As written, the metabolite DUI provision in Florida Senate Bill 1118, would merely require the prosecution prove that a defendant had, in his or her urine or blood, metabolites indicating prior exposure to a controlled substance while driving.

Under Florida Law, the term “prescription” is defined in Florida Statute 893.02(22). Section 316.193(d) of the proposed DUI legislation provides an affirmative defense for individuals who have been legally prescribed a controlled substance. However, this affirmative defense would not apply to DUI prosecutions based on the use of medical marijuana. The United States Drug Enforcement Agency has exclusive regulatory control over the prescription of controlled substances. All doctors in all 50 states are prohibited from prescribing a Schedule I controlled substance. Doctors can be stripped of their ability to prescribe medications and prosecuted in Federal Court for writing a prescription for a Schedule I Controlled Substance. The proposed constitutional amendment which would legalize the use of medical marijuana in Florida does not grant a physician the authority to “prescribe” marijuana. In order to avoid running afoul of federal law, the proposed constitutional amendment permits a doctor to issue a “physician certification.” Section (b)(9) of the proposed constitutional amendment specifically defines “physician certification” which is significantly different from the definition of “prescription” as defined in Florida Statute 893.02(22). Therefore, the proposed affirmative defense for individuals legally prescribed a controlled substance will not be available to users of medical marijuana because neither the state or the DEA permit a doctor to write a prescription for marijuana.

Fort Lauderdale DUI attorney, Michael Dye, stated: “The scariest thing about Senate Bill 1118 is that it redefines the crime of DUI so that the state is not required to prove impairment in order get a conviction. This bill adds a metabolite drug provision with regard to Chapter 893 Florida Statutes and Schedule I Controlled Substances in the Federal Register. This means that the state does not have to prove that driver was high while driving. Inactive metabolites of marijuana can be detected in urine a long time after a person consumed marijuana. Inactive metabolites only indicate prior use, but can not be used to determine the time or quantity of ingestion. If this bill is passed, a chemotherapy patient who ingested marijuana two days before getting pulled over would be guilty of DUI even though there is no active THC in his or her system and there would be no impact on his or her driving. I encourage individuals to contact their individual representatives and let them know to vote no on this bill.”
ABOUT THE LAW OFFICES OF MICHAEL A. DYE, PA: Michael Dye is a criminal defense attorney with offices located in Fort Lauderdale and Miami, Florida. The firm represents individuals charged with DUI and other criminal offenses in State and Federal Courts throughout Florida. More information on the firm and Mr. Dye is available by contacting us at The Law Offices of Michael A. Dye, PA, 1 E Broward Blvd, Fort Lauderdale, FL 33301, (954)990-0525 or (888)959-6936. You can also visit the firm website at: Fort Lauderdale DUI Attorney or Miami DUI Attorney.

Michael Dye, The Law Offices of Michael A. Dye, PA, http://YourFloridaCriminalAttorney.com, +1 (954) 990-0525, [email protected]

Modal title

Sample Letter to Send to Your State Senator or Congressman
Sample Letter to Send to Your State Senator or Congressman
Find Your Representative
View PDF
Find Your Representative
Sample Letter to Send to Your State Senator or Congressman Find Your Representative

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.